Vitamin D status in HIV-infected patients with and without tuberculosis: A pilot study

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 2, 2012, Pages

  Steenhoff, Andrew P ^a,b   Redwood, Abiona ^c   Pettifor, John M ^d   Hove, Joseph ^b   Bisson, Gregory P ^b,e   Mosepele, Mosepele ^e   Pusoesele, Phillip ^b   Thakur, Rameshwari ^b   Kovarik, Carrie ^b,e   Gross, Robert ^b,e  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b BOTSWANA UPENN PARTNERSHIP   (Botswana)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; BOTSWANA; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PILOT STUDY; PRIORITY JOURNAL; TUBERCULOSIS; VITAMIN DEFICIENCY;

ADULT; BOTSWANA; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; PILOT PROJECTS; TUBERCULOSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84866920861     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182683cd2     Document Type: Letter

References (10)

1. Botswana Ministry of Health. Botswana national HIV/AIDS treatment guidelines: 2008 version. Available at: http://www.gov.bw/en/Ministries- Authorities/Ministries/MinistryofHealth-MOH/Reports-and-Publications/. Accessed April 8, 2011.
2. Fountain FF, Tolley E, Chrisman CR, et al. Isoniazid hepatotoxicity associated with re-atment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic. Chest. 2005; 128:116-123.
3. Liu PT, Stenger S, Tang DH, et al. Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007;179:2060-2063.
4. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006;38:3-5.
5. Baeke F, Takiishi T, Korf H, et al. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10:482-496.
6. WHO. Botswana health profile. 2010. Available at: http://www.who.int/gho/ countries/bwa.pdf. Accessed April 2011.
7. Williams SE, Wardman AG, Taylor GA, et al. Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism. Tubercle. 1985;66:49-54.
8. Akksilp S, Karnkawinpong O, Wattanaamornkiat W, et al. Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-in-fected patients in Thailand. Emerg Infect Dis. 2007;13:1001-1007.
9. Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from Sub-Saharan Africa. Clin Infect Dis. 2008;46:443-446.
10. Friis H, Range N, Pedersen ML, et al. Hypo-vitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr. 2008;138:2474-2480.